HRSA HAB Update - Special Bulletin on MPx


HRSA HIV/AIDS Bureau Update - Special Bulletin on MPx

The Health Resources and Services Administration’s (HRSA) HIV/AIDS Bureau (HAB) shares the following monkeypox (MPx) updates with our Ryan White HIV/AIDS Program (RWHAP) recipients, subrecipients, national partners, and federal colleagues.

White House Monkeypox Response Team Announces New Plans to Support Large LGBTQI+ Events and Equity Interventions to Reach Communities at Highest Risk of Contracting the Virus.

The White House released a fact sheet on August 30, 2022, announcing new actions the Biden-Harris Administration is taking to combat the MPx outbreak and protect individuals most at risk. The Administration is providing additional vaccines and support to states and cities holding events that convene large groups of LGBTQI+ individuals, specifically gay, bisexual, and other men who have sex with men (MSM). These include Southern Decadence in New Orleans, Louisiana; Atlanta Black Pride in Atlanta, Georgia; and Pridefest in Oakland, California.

As part of a pilot program announced earlier this month, the Biden-Harris Administration is making additional vaccines available to these jurisdictions and providing additional support on the ground, including increased access to testing and other prevention resources.

Read the fact sheet to learn more.

HRSA MPx Vaccine Distribution Initiative – Vaccine Distribution to Ryan White HIV/AIDS Program Part C Dually Funded Health Center Program Recipients 

HRSA received an allotment of the JYNNEOS vaccine for MPx for rapid distribution to RWHAP Part C dually funded Health Center Program providers that care for a significant number of MSM and transgender persons. The identified providers already have access to the Health Partner Ordering Portal, which aided in quickly getting the vaccine to clients.

To learn more and to view the list of providers, visit the HRSA MPx Vaccine Distribution Initiative Web Page.

HRSA Monkeypox Information Web Page

The HRSA HAB MPx Information Web Page has been updated with new MPx resources, including the following from the CDC:  

Seven Questions on Monkeypox Vaccines with Dr. Daskalakis

CDC and FDA Update: Interim Clinical Considerations for Monkeypox Vaccination

Vaccine Administration Errors and Deviations

How to Administer the JYNNEOS Vaccine Intradermally

Testing Patients for MPx (PDF – 1MB)

Preparation and Collection of Specimens

Disinfecting Home and Other Non-Healthcare Settings

MMWR: High-Contact Object and Surface Contamination in a Household of Persons with Monkeypox Virus Infection — Utah, June 2022

We'd like your feedback

Was this page helpful?
I found this page helpful because the content on the page:
Check all that apply
I did not find this page helpful because the content on the page:
Check all that apply
Please include an email address if you would like a response
Please include an email address if you would like a response
Did you use this approach in your work?
Not yet because
If no, why not?